A trial to find out how well CVHNLC works at different dose levels and how safe it is in combination with pembrolizumab in patients with lung cancer that cannot be completely cured.
CV-HNLC-001
Phase 1 other active
Quick answer
A trial to find out how well CVHNLC works at different dose levels and how safe it is in combination with pembrolizumab in patients with lung cancer that cannot be completely cured. for metastatic squamous non-small cell lung cancer is a Phase 1 program (other) at CureVac AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CureVac AG
- Indication
- metastatic squamous non-small cell lung cancer
- Phase
- Phase 1
- Modality
- other
- Status
- active